Beschreibung
InhaltsangabeTable of Contents Preface Chapter 1: Renal Cell Carcinoma: Background, Ronald M. Bukowski MD, Andrew Novick MD Chapter 2: Imaging of Renal Cell Carcinoma, Brian R. Herts, MD Chapter 32: The Role of Percutaneous Imaging Guided Biopsy in the Diagnosis and Management of Renal Masses, Brian R. Herts, MD, Stuart G. Silverman, MD Chapter 4: Pathology of Renal Cell Carcinomas, Ming Zhou, M.D., Ph.D Chapter 5: The Epidemiology of Renal Tumors, Jeffrey S. Montgomery, MD, David P. Wood, MD Chapter 6: Molecular Genetics in Inherited Renal Cell Carcinoma: Identification of Targets in the Hereditary Syndromes, Nadeem Dhanani, Cathy Vocke, Gennady Bratslavsky and W. Marston Linehan Chapter 7: T Cell Unresponsiveness in RCC patients, James H Finke PhD and Mahesh Goel MD Chapter 8: Renal Cell Carcinoma: Clinical Presentation and Diagnosis, Venkatesh Krishnamurthi, M.D. Chapter 9: Clinical and Pathologic Staging of Renal Cell Carcinoma, Alison M. Lake, Cara Cimmino, James E. Montie and Khaled S. Hafez Chapter 10: Active Surveillance of Localized Renal Tumors, Paul L. Crispen, M.D., Robert G. Uzzo, M.D. Chapter 11: Radical nephrectomy, Dr. John Libertino Chapter 12: Laporoscopic Radical Nephrectomy, Benjamin I.Chung, Jose R. Colombo Jr, Inderbir S. Gill Chapter 13: Open Nephron-Sparing Surgery for Renal Cell Carcinoma, Andrew C. Novick, M.D. Chapter 14: Minimally Invasive Nephron Sparing Surgery (MINSS) for Renal Tumors: Laparoscopic Partial Nephrectomy and Probe Ablative Treatments, Monish Aron, Georges-Pascal Haber, Inderbir S. Gill Chapter 15: The Role of Angioinfarction in the Management of Renal Tumors, Bryan T. Kansas, MD, Paul L. Crispen, MD, Robert G. Uzzo, MD Chapter 16: Surveillance Strategies Following Curative Therapy for Localized Renal Cell Carcinoma, Vitaly Margulis, MD, Surena Matin, MD, and Christopher G. Wood, MD Chapter17: Local Recurrence of Renal Cell Carcinoma: Management, Brian K. McNeil, MD, Steven C. Campbell, MD, PhD Chapter 18: Adjuvant Therapy of Renal Cell Carcinoma, Ronald M. Bukowski, M.D. Chapter 19: Prognostic Factors for Survival in Metastatic Renal Cell Carcinoma, Paul J. Elson, Sc.D. Chapter 20: Functional Imaging of Renal Cell Cancer, Navneet S Majhail, MD, Ronald M Bukowski, MD Chapter 21: Nephrectomy in Patients With Metastatic Renal Cell Carcinoma: Clinical and Biologic Effects, Bradley G. Orris, M.D., Robert C. Flanigan, M.D. Chapter 22: Spontaneous Regression of Renal Cell Cancer and the Role of Prognostic Factors, Tim Oliver, Tom Powles, Vinod Nargund, Dan Berney Chapter 23: Clinical Management of Renal Cell Carcinoma, Thomas E. Hutson, DO, PharmD Chapter 24: Chemotherapy for Metastatic Clear Cell Renal Cell Cancer, James O. Jin, M.D. Ph.D., Walter M. Stadler, M.D. Chapter 25: Signal Transduction Inhibitors in Renal Cell Carcinoma, Ellen A. Ronnen MD, Saby George MD, Ronald M. Bukowski MD, Robert J. Motzer MD Chapter 26: Pulmonary Metastases in Patients with Advanced Renal Cell Carcinoma: Role of Metastasectomy, Sudish Murthy, MD, Ph.D., FACS, FCCP Chapter 27: Management of Skeletal Metastases in Renal Cell Carcinoma Patients, Michael J. Joyce, M.D. Chapter 28: Renal Cell Carcinoma Metstatic to the Pancreas: Clinical and Therapeutic Aspects, Ahmed Al-Hazzouri, Brian Herts, Ronald M. Bukowski Chapter 29: Intracranial Renal Cell Cancer Metastasis, Kene Ugokwe, M.D. Steven A. Toms, M.D., M.P.H. Chapter 30: Role of Radiation Therapy in Advanced Renal Cell Carcinoma, Arul Mahadevan, MD FRCS Chapter 31: Palliation in Renal Cancer, Mellar P. Davis, MD FCCP Chapter 32: Management of Patients With Pathologic Variants of Renal Cell Carcinoma: Papillary, Collecting Duct, Medullary and Chromophobe Carcinoma, and Sarcomatoid Dedifferent
Produktsicherheitsverordnung
Hersteller:
Humana Press in Springer Science + Business Media
juergen.hartmann@springer.com
Heidelberger Platz 3
DE 14197 Berlin